Home

Bioworkshops sell "Sotatercept-csrk"

Basic Information

1.2K
97
16
4.1(28)

Trade Type

Sell

Product Name

Sotatercept-csrk

Manufacturer(s)

Specifications

  • Expression System: Developed from a DMF-filed mammalian cell line optimized for consistently high titer, supporting cost-efficient large-scale manufacturing and broad media-platform adaptability
  • Regulatory Status: Biosimilar of sotatercept (ACVR2A/ACTRIIA inhibitor mAb, originator Acceleron Pharma, US approval 2024-03-26), demonstrating high analytical comparability to the reference product
  • Application: Targets ACTRIIA (ACVR2A) for cardiovascular, respiratory, endocrine and metabolic disorders, with pulmonary arterial hypertension (PAH) as a representative indication
  • Certification Standard: Regulatory compliance ensured through a DMF-filed cell line, supporting global regulatory readiness and streamlined submissions

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product